Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.

NCT05852418 — Completed, 25000 participants, Ambulanzpartner Soziotechnologie APST GmbH

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Registry Study of the Provision of Assistive Devices, Medicines, and Other Healthcare Measures in an Inter-cohort Observation of Patients With ALS , SMA and Other Neurological Diseases.

RegistryNCT05852418
StatusCompleted
Study typeObservational
Enrollment25000 (Estimated)
SponsorAmbulanzpartner Soziotechnologie APST GmbH (Industry); collaborators: Charite University, Berlin, Germany
ConditionsAmyotrophic Lateral Sclerosis
Datesstart 2015-10-30, primary completion 2024-12-01, completion 2024-12-01, first posted 2023-05-10, last updated 2026-10-19
Locations16 sites in Germany

Related Papers Related Patents Related Grants Related Experts
All trials for Amyotrophic Lateral Sclerosis

-Summary

This registry study aims to collect data on the provision of assistive devices, medicines, and other healthcare measures, such as ventilation therapy and nutrition support, in patients with Amyotrophic lateral sclerosis (ALS), Spinal muscular atrophy (SMA) and other neurological disorders. The data collected should describe the clinical practice, meaning real-world evidence and patient-reported outcomes.

Expand all sections  ·  Collapse all

+Detailed description

This registry study aims to collect data on the provision of assistive devices, medicines, and other healthcare measures, such as ventilation therapy and nutrition support, in patients with ALS, SMA and other neurological disorders. The data collected should describe the clinical practice, meaning real-world evidence and patient-reported outcomes. The collected data include clinical characteristics, medical history, assessment scales, such as ALS functional rating scale-revised (ALSFRS-R), prognosis indicators, such as ALS progression rate, biomarker data, such as serum Neurofilament light chain (sNfL), genetic data, such as the mutation status of SOD1, FUS, c9orf72, TARDBP in ALS, SMN1 in SMA patients, innovative drugs such as Tofersen, Nusinersen, Risdiplam, as well as symptomatic drugs, patient-reported outcome data being captured using questionnaires and established clinical scales on medication expectation and treatment satisfaction.

+Outcome measures

Primary outcomes

  • The systematic recording of neurological treatment and its evaluation by patients via specific questionnaires [10 years]: The systematic recording of neurological treatment and its evaluation by patients via specific questionnaires

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria: Diagnosis of a chronic neurological disease -

Exclusion Criteria: Lack of cooperation and unwillingness to store and share medical data collected in the registry study

\-

+Locations (16)

FacilityCityCountryStatus
Christoph MünchBerlin, State of BerlinGermany
Neurologische Klinik und Poliklinik, Universitätsklinikum BergmannsheilBochumGermany
Klinik für Neurodegenrative Erkrankungen und Gerontopsychiatrie, ALS-Ambulanz und Huntington Ambulanz, UniversitätsklinikumBonnGermany
Klinik und Poliklinik für Neurologie, Medizinische Fakultät Carl Gustav Carus, Technischen Universität DresdenDresdenGermany
Neurologische Klinik, ALS-Ambulanz, Alfried Krupp Krankenhaus Rüttenscheid, EssenEssenGermany
Klinik für Neurologie, Universitätsmedizin, Georg-August-Universität GöttingenGöttingenGermany
ALS- und Muskelambulanz, Medizinische Hochschule HannoverHanoverGermany
Neurologie und Poliklinik, UniversitätsklinikumHeidelbergGermany
Ambulanz für Neuromuskuläre und Motoneuron-Erkrankungen, Universitätsklinikum JenaJenaGermany
Klinik und Poliklinik für NeurologieLeipzigGermany
Klinik für Neuroogie-Präzisionsneurologie, Universitätsklinikum Schleswig-Holstein, Universität zu LübeckLübeckGermany
Neurologisches Klinik, Ambulanz für Motoneuronerkrankungen und ALS, DiakonissenkrankenhausMannheimGermany
UniversitätklinikumMannheimGermany
Klinik und Poliklinik für Neurologie, Klinikum rechts der Isar der Technischen Universität MünchenMünchenGermany
Klinik für Schlafmedizin und Neuromuskuläre Erkrankungen, Westfälische Willhelms-Universität MünsterMünsterGermany
Klinik für Innere Medizin, Neurologie, UKM Marienhospital SteinfurtSteinfurtGermany

+Study documents

+Investigators